Autonomix Medical, Inc.
Cash Flow Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | $-16.7M | $-11.4M | $-15.4M | $-2.0M |
| Depreciation & Amortization | $12.0K | $183.0K | $81.0K | $0 |
| Depreciation | — | — | — | — |
| Amortization | — | — | — | — |
| Stock-Based Compensation | $529.0K | $1.6M | $618.0K | $0 |
| Net Cash from Operating Activities | $-12.3M | $-8.3M | $-6.6M | $-1.9M |
| Investing Activities | ||||
| Capital Expenditures | $10.0K | $14.0K | $19.0K | $0 |
| Business Acquisitions | — | — | — | — |
| Net Cash from Investing Activities | $-10.0K | $-14.0K | $-19.0K | $0 |
| Financing Activities | ||||
| Dividends Paid | — | — | — | — |
| Stock Repurchases | — | — | — | — |
| Net Cash from Financing Activities | $10.2M | $8.8M | $14.4M | $675.0K |
| Net Change in Cash | $-2.1M | $528.0K | $7.7M | $-1.2M |
| Free Cash Flow | $-12.3M | $-8.3M | $-6.6M | $-1.9M |